Document Detail

Approaching Ewing sarcoma.
MedLine Citation:
PMID:  20624127     Owner:  NLM     Status:  MEDLINE    
Although Ewing sarcoma represents a rare malignancy of childhood and adolescence, it has attracted the attention of an increasing number of excellent researchers. With a tumor-specific EWS-ETS translocation coding for a transcription factor, which obviously profoundly modifies the intracellular signaling network, this rare malignancy opens insights in pathological gene and protein regulation. Despite decades of basic and translational research, clinical improvement has not yet been modulated by novel targeted therapies, but is produced by well-designed multimodal treatments. By using these multimodal treatment approaches, which always include chemotherapy and local treatment, the prognosis has been improved by up to 70%. For more than 10 years, the survival curves have plateaued at a relatively high level. However, a 30% relapse rate is still unacceptably high, considering that the prognosis after relapse is fatal for most patients. Therefore, novel treatment approaches are urgently required. This article provides an overview of the Ewing sarcoma research of the past few years; while not claiming to be complete, it offers a view on putative strategies with translational potential.
Uta Dirksen; Heribert Jürgens
Related Documents :
24572917 - Psychological factors in the assessment of disability among patients with chronic pain.
24002987 - Research applications for an object and action naming battery to assess naming skills i...
23520707 - Rigour in qualitative case-study research.
24618067 - A historical approach to scorpion studies with special reference to the 20th and 21st c...
22122367 - Understanding concerns about interventions to promote forgiveness: a review of the lite...
23432217 - Challenges in exploring the cytochrome p450 system as a source of variation in canine d...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Future oncology (London, England)     Volume:  6     ISSN:  1744-8301     ISO Abbreviation:  Future Oncol     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-13     Completed Date:  2010-10-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101256629     Medline TA:  Future Oncol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1155-62     Citation Subset:  IM    
Pediatric Hematology & Oncology, Albert-Schweitzer Str. 33, 48149 Münster, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Gene Expression Regulation, Neoplastic
RNA-Binding Protein EWS / genetics,  metabolism
Research / trends
Sarcoma, Ewing's / physiopathology*,  therapy*
Stem Cell Transplantation
Translational Research
Reg. No./Substance:
0/RNA-Binding Protein EWS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Advances in fluorescence imaging techniques to detect oral cancer and its precursors.
Next Document:  Use of immunohistochemistry in the diagnosis of melanocytic lesions: applications and pitfalls.